Form 8-K - Current report:
SEC Accession No. 0001213900-20-004698
Filing Date
2020-02-25
Accepted
2020-02-25 08:40:06
Documents
2
Period of Report
2020-02-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k022520_citiuspharma.htm 8-K 17954
2 PRESS RELEASE DATED FEBRUARY 25, 2020 f8k022520ex99-1_citiuspharma.htm EX-99.1 16072
  Complete submission text file 0001213900-20-004698.txt   35313
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 20647602
SIC: 2834 Pharmaceutical Preparations